25 reports

  • ECONOMIC

P A G E | ## ## Table ##: Diabetes Prevalence, 2017 Country P A G E | ## ## countries European countries have low diabetes prevalence in 2017.

  • Diabetes
  • World
  • Forecast
  • Market Size
  • Roche Group
  • ECONOMIC

P A G E | ## ## Table ##: Diabetes Prevalence, 2017 Country P A G E | ## ## countries European countries have low diabetes prevalence in 2017.

  • Diabetes
  • World
  • Forecast
  • Market Size
  • Roche Group
  • INSULIN MARKET IN US AND EUROPE BY APPLICATION 2015
  • Market segmentation by application

Lifestyle factors may include cigarette smoking, alcohol consumption, physical inactivity, and a sedentary lifestyle.

  • Diabetes
  • Eli Lilly & Co.
  • Novo Nordisk Group
  • Oramed Pharmaceuticals Inc.
  • Sanofi S.A.
  • Market segmentation by type of disease

Lifestyle factors may include cigarette smoking, alcohol consumption, physical inactivity, and sedentary lifestyle.

  • Diabetes
  • World
  • Lilly Endowment Inc.
  • Novo Nordisk Group
  • Sanofi S.A.
  • 3 Disease Background

Circulation; ##(##): ##-##.

  • Diabetes
  • China
  • United States
  • World
  • Forecast

SR ONE ##.

  • Diabetes
  • North America
  • United States
  • Ironwood Pharmaceuticals, Inc.
  • Novo Nordisk Group

HTLV-## = human T-cell lymphotropic virus type ##.

  • Diabetes
  • World
  • Cepheid
  • Hologic, Inc.
  • Roche Group
  • ELAMIPRETIDE - DRUG PROFILE

In January 2012, Stealth Peptides registered a Phase I trial of Bendavia (MTP-##) for the treatment of endothelial reactivity dysfunction induced by cigarette smoking.

  • Diabetes
  • Neurology
  • Therapy
  • Type 2 Diabetes
  • Santhera Pharmaceuticals Holding AG
  • PIPELINE BY JAPAN TOBACCO INC, H2 2018

Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes.

  • Diabetes
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • ELAMIPRETIDE - DRUG PROFILE

In January 2012, the company registered a Phase I trial of Bendavia (MTP-##) for the treatment of endothelial reactivity dysfunction induced by cigarette smoking.

  • Diabetes
  • Neurology
  • Therapy
  • United States
  • Product Initiative
  • SUL-121 - DRUG PROFILE

Under the offering, the entitlement ratio will be ##:##.

  • Diabetes
  • United States
  • Company
  • Product Initiative
  • ProMetic Life Sciences Inc.
  • ELAMIPRETIDE - DRUG PROFILE

In January 2012, Stealth Peptides registered a Phase I trial of Bendavia (MTP-##) for the treatment of endothelial reactivity dysfunction induced by cigarette smoking.

  • Diabetes
  • Health Services
  • Therapy
  • United States
  • Product Initiative
  • TYPE2 DIABETES - PIPELINE BY IONIS PHARMACEUTICALS INC,

TABLE ##: TYPE## DIABETES - PIPELINE BY IONIS PHARMACEUTICALS INC, Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes.

  • Diabetes
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative

(JT Group) is a tobacco company that manufactures and sells tobacco products, primarily cigarettes.

  • Diabetes
  • Pharmaceutical
  • Japan
  • World
  • Product Initiative
  • 4.1 Growth Drivers

Often, the symptoms of type ## are sudden and severe.

  • Diabetes
  • Diabetes Monitoring
  • Patient Monitoring
  • United States
  • DexCom, Inc.
  • Global Diabetes Statistics (2014)
  • 6.1 Growth Drivers

A person smoking a pack of cigarette each day has twice the chance to suffer a heart attack than a non-smoker.

  • Diabetes
  • Implantable Delivery
  • Interventional Cardiology Device
  • World
  • Medtronic, Inc.

LUNDBECK A/ S FINANCIAL ADVISOR RANKING BY VALUE ($M) Volume ## Value ($m) ## Volume ## Value ($m) ## TARGETS AND PARTNERS TARGETS AND PARTNERS H.

  • Diabetes
  • Neurology
  • United States
  • Company
  • H. Lundbeck A/S

LUNDBECK A/ S FINANCIAL ADVISOR RANKING BY VALUE ($M) Volume ## Value ($m) ## Volume ## Value ($m) ## TARGETS AND PARTNERS TARGETS AND PARTNERS H.

  • Diabetes
  • Neurology
  • United States
  • Company
  • H. Lundbeck A/S
  • SUL-121 - DRUG PROFILE

## ## Preclinical ## ## Discovery ## ## Unknown ## ## Total ## ## Products in Phase II/ III and I/ II are reflected under Phase III and Phase II, respectively Source: Global Markets Direct NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR DIABETIC NEPHROPATHY, H## 2018 Stage of Development C

  • Diabetes
  • Digestive System Disorder
  • Type 2 Diabetes
  • United States
  • Product Initiative
  • TYPE 2 DIABETES - PIPELINE BY IXCHEL PHARMA, LLC, H2 2016
  • TYPE 2 DIABETES - PIPELINE BY JAPAN TOBACCO INC., H2 2016

(JT Group) is a tobacco company that manufactures and sells tobacco products, primarily cigarettes.

  • Biotechnology
  • Diabetes
  • Type 2 Diabetes
  • Company
  • Product Initiative

PATIENTS AT BASELINE WERE DEPENDENT ON NICOTINE AND AVERAGED ## CIGARETTES PER DAY.

  • Diabetes
  • United States
  • Company
  • Company Operations
  • Product Initiative

Patients at baseline were dependent on nicotine and averaged ## cigarettes per day.

  • Diabetes
  • Obesity
  • Pharmaceutical
  • Therapy
  • Omeros Corporation

According to CDC, cigarette smoking is responsible for over ##, ## deaths every year in the U. S.

  • Diabetes
  • North America
  • United States
  • Market Size
  • Omada Health, Inc.
  • Indication Name
  • TYPE2 DIABETES - PIPELINE BY JAPAN TOBACCO INC, H1 2018

TYPE## DIABETES - PIPELINE BY INTREXON CORP, H## 2018 IONIS PHARMACEUTICALS INC TYPE## DIABETES - PIPELINE BY IONIS PHARMACEUTICALS INC, H## 2018 Product Name Indication Name Stage of Development Territory Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes.

  • Biopharmaceutical
  • Diabetes
  • Pathology
  • United States
  • Company
  • TYPE 2 DIABETES - PIPELINE BY ISLET SCIENCES INC, H2 2017
  • TYPE 2 DIABETES - PIPELINE BY IONIS PHARMACEUTICALS INC, H2 2017

ISLET SCIENCES INC Japan Tobacco Inc (JT Group) is a tobacco company that primarily manufactures cigarettes.

  • Biopharmaceutical
  • Diabetes
  • Pathology
  • Type 2 Diabetes
  • Company